What is overlap weighting, how has it evolved, and when to use it for causal inference?
International Journal of Epidemiology · 14.10.2026 · 55 (6)
DOI: 10.1093/ije/dyag249 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Epidemiology, online erschienen am 04.11.2026. Verfasst von Haidong Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States. Hauptthemen laut MEDLINE: Observational Studies as Topic, Causality. Die Arbeit nennt 23 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The growing availability of large healthcare databases has expanded the use of observational studies for comparative effectiveness research. Unlike randomized trials, observational studies must adjust for systematic differences in patient characteristics between treatment groups. Propensity score methods, including matching, weighting, stratification, and regression adjustment, address this issue by creating groups that are comparable with respect to measured covariates. Among these approaches, overlap weighting (OW) has emerged as a principled and efficient method that emphasizes individuals at empirical equipoise, those who could plausibly receive either treatment. By assigning weights proportional to the probability of receiving the opposite treatment, OW targets the average treatment effect in the overlap population, achieves exact mean covariate balance under logistic propensity score models, and minimizes asymptotic variance. Over the last decade, the OW method has been recognized as a valuable confounding adjustment tool across the statistics, epidemiology, and clinical research communities and is increasingly applied in clinical and health studies. Given the growing interest in using observational data to emulate randomized trials and the capacity of OW to prioritize the region of empirical equipoise in the observed data, which under some conditions approximates, but is not equivalent to, the population that a pragmatic randomized trial would enroll while achieving covariate balance (fundamental attributes of randomized studies), this article provides a concise overview of recent methodological developments in OW and practical guidance on when it represents a suitable choice for causal inference.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States.
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States.
- Department of Statistical Science, Duke University, Durham, NC, United States.
- Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, United States.
- Duke Clinical Research Institute, Durham, NC, United States.
- Department of Biostatistics, Yale School of Public Health, New Haven, CT, United States.
ORCID-Profile: Haidong Lu, Laine E Thomas, Fan Li
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Lu, H., Li, F., Thomas, L. E., & Li, F. (2026). What is overlap weighting, how has it evolved, and when to use it for causal inference?. International Journal of Epidemiology, 55(6). https://doi.org/10.1093/ije/dyag249
Vancouver
Lu H, Li F, Thomas LE, Li F. What is overlap weighting, how has it evolved, and when to use it for causal inference?. International Journal of Epidemiology. 2026;55(6). doi:10.1093/ije/dyag249
BibTeX
@article{Lu2026,
author = {Lu, Haidong and Li, Fan and Thomas, Laine E and Li, Fan},
title = {What is overlap weighting, how has it evolved, and when to use it for causal inference?},
journal = {International Journal of Epidemiology},
year = {2026},
volume = {55},
number = {6},
doi = {10.1093/ije/dyag249}
}
EUVIMED